Correction to: 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

HomeCirculationVol. 139, No. 14Correction to: 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Originally published1 Apr 2019https://doi.org/10.1161/CIR.0000000000000683Circulation. 2019;139:e833–e834This article corrects the following2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesIn the article by Stout et al, “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” which published ahead of print on August 16, 2018, and appeared in the April 2, 2019, issue of the journal (Circulation. 2019;139:e698–e800. DOI: 10.1161/CIR.0000000000000603), several corrections were needed.On page e698, in the “Writing Committee Members” section, “FACC” is added to the credentials for Dr. Van Hare.On page e712, in “Table 6. Delivery of Care: Circumstances Where ACHD Expertise May Improve Outcomes,” second row “Patients with ACHD and pulmonary hypertension,” last column “Example,” in the second sentence, the measurement for Wood units read “Wood units/m2.” It is updated to read, “Wood units x m2.”On page 715, in the “3.4.6. Cardiac Catheterization” section, in the recommendation table, the recommendations were numbered “2” and “3.” They are renumbered as “1” and “2.”On page e724, in the “3.15. Palliative Care,” “Recommendation-Specific Supportive Text” section, in the left-hand column, first paragraph, the third sentence read, “There is a discrepancy between patient-reported interest in discussing advanced directives….” It is updated to read, “There is a discrepancy between patient-reported interest in discussing advance directives….”On page e749, in the “4.3.5. Tetralogy of Fallot” section, in the recommendation table, the recommendations were numbered, “5, 7, 8, 9, and 10.” They are renumbered as “5, 6, 7, 8, 9.”On page e750, in “Figure 4. Pulmonary valve replacement in patients with TOF repair and PR,” sixth row, in the large white diamond, a dagger symbol was added to the text. It now reads, “Any 2 of the following†:…”On page e750, in the legend to “Figure 4. Pulmonary valve replacement in patients with TOF repair and PR,” the following sentence was added: “†See recommendation 6 supporting text.”On page e752, in the “4.3.5. Tetralogy of Fallot” section, the left-hand column, the first paragraph of the “Recommendation-Specific Supportive Text” for Recommendation 6 read,6. Pulmonary valve replacement is reasonable in patients with at least 2 of the following (S4.3.5-1, S4.3.5- 9, S4.3.5–12–S4.3.5–14): a. Mild or greater RV or LV dysfunctionb. Severe RV dilation (RV end-diastolic volume index ≥160 mL/m2, RV end-systolic volume index ≥80 mL/m2)c. RV end-diastolic volume ≥2 times the LV end-diastolic volumed. RV systolic pressure two thirds or higher systemic pressuree. Progressive objective reduction in exercise capacityIt has been updated to read,6. There are data that indicate that pulmonary valve replacement performed prior to specific ventricular size is associated with normalization of RV volumes. However, it is not yet evident that this correlates with an improvement in mortality. Clinically, it therefore is most compelling to perform pulmonary valve replacement if 2 of the following are met:S4.3.5-1, S4.3.5–9, S4.3.5–12–S4.3.5–14a.Mild or moderate RV or LV systolic dysfunctionb.Severe RV dilation (RV end-diastolic volume index ≥160 mL/m2, or RV end-systolic volume index ≥80 mL/m2, or RV end-diastolic volume ≥2x LV end-diastolic volume).c. RV systolic pressure due to RVOT obstruction ≥2/3 systemic pressured. Progressive reduction in objective exercise tolerance9. On page e763, in the “4.4.6.1. Severe PAH” section, the recommendation table, in Recommendation 1, the measurement for Wood units read “Wood units/m2.” It is updated to read, “Wood units x m2.”10. On page e796, “Appendix 1. Author Relationships With Industry and Other Entities (Relevant)—2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease* (February 2018),” in the entries for Dr. Aboulhosn and Dr. Khairy, the last column “Recusals by Section,” one of the sections read, “4.3.1.2.” It is updated to read, “4.3.2.”11. On page e796, “Appendix 1. Author Relationships With Industry and Other Entities (Relevant)—2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease* (February 2018),” the entry for Dr. Crumb’s Employment is updated to read, “Nationwide Children’s Hospital.”12. On pages e798 and e799, “Appendix 2. Reviewer Relationships With Industry and Other Entities (Comprehensive)—2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease (February 2018),” the information for Sana M. Al-Khatib was moved to before Naser Ammash to be listed in alphabetical order.These corrections have been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIR.0000000000000603.Footnoteshttps://www.ahajournals.org/journal/circ Previous Back to top Next FiguresReferencesRelatedDetailsCited By Kearney K, Zentner D and Cordina R (2021) Management of Maternal Complex Congenital Heart Disease During Pregnancy, Current Heart Failure Reports, 10.1007/s11897-021-00534-x, 18:6, (353-361), Online publication date: 1-Dec-2021. Leczycki P, Banach M, Maciejewski M and Bielecka-Dabrowa A (2022) Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.692815, 9 Bloria S, Bajaj R, Luthra A and Chauhan R (2020) Managing Heart Disease in Pregnancy, European Medical Journal, 10.33590/emj/19-00131, (58-66) Chazova I, Gorbachevskij S, Martynyuk T, Shmal’c A, Valieva Z, Baryshnikova I, Glushko L, Gramovich V, Azizov V, Veselova T, Danilov N, Zelveyan P, Ivanov S, Lazareva I, Matchin Y, Mukarov M, Nakonechnikov S, Sarybaev A, Stukalova O and Shalaev S (2022) Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021), Eurasian heart journal, 10.38109/2225-1685-2022-2-6-70:2, (6-70) Chazova I, Gorbachevskij S, Martynyuk T, Shmal’c A, Valieva Z, Baryshnikova I, Glushko L, Gramovich V, Azizov V, Veselova T, Danilov N, Zelveyan P, Ivanov S, Lazareva I, Matchin Y, Mukarov M, Nakonechnikov S, Sarybaev A, Stukalova O and Shalaev S (2022) Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021), Eurasian heart journal, 10.38109/2225-1685-2022-1-6-70:2, (6-70) Related articles2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesKaren K. Stout, et al. Circulation. 2019;139:e698-e800 April 2, 2019Vol 139, Issue 14 Advertisement Article InformationMetrics © 2019 American Heart Association, Inc.https://doi.org/10.1161/CIR.0000000000000683PMID: 30933622 Originally publishedApril 1, 2019 PDF download Advertisement